跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
羟考酮纳洛酮缓释片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-release Tablets
Approved
化学药品
Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-release Tablets
NAPP PHARMACEUTICALS LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Apr 12, 2023
Approval ID
58e9f27fae7128e5
Company
NAPP PHARMACEUTICALS LIMITED
Type
化学药品
Approval Details
Approval Id
58e9f27fae7128e5
Approval Number
国药准字HJ20220088
Generic Name
羟考酮纳洛酮缓释片
Generic Name En
Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-release Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含盐酸羟考酮10mg与盐酸纳洛酮5mg
Reg Date
2023-04-12
Expired Date
2027-11-21
Company Name
NAPP PHARMACEUTICALS LIMITED
Production Company Name
BARD PHARMACEUTICALS LIMITED
Company Detail Path
/organization/napp-pharmaceuticals-limited
Production Company Detail Path
/organization/bard-pharmaceuticals-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 12, 2023
Approval ID
58e9f27fae7128e5
Type
化学药品
Back to NMPA Approvals